Government work isn’t what it used to be.
The immediate impetus for FDA Commissioner Marty Makary’s exit from the top job at FDA is arguably less significant than the legacy of dysfunction he leaves behind.
Backlog of work grows at NIH as staff members are being hounded to quit
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Table of Contents
YOU MAY BE INTERESTED IN
The Earle A. Chiles Research Institute, a division of the Providence Cancer Institute of Oregon, received an NIH grant for its next phase of treatments for head-and-neck cancers.
Northwestern Mutual, through its Foundation, announced a class of scholars from its annual Childhood Cancer Scholarship Program for families affected by childhood cancer. The program provides scholarships to students affected by a diagnosis—either as survivors themselves or as siblings—enabling recipients to chase their dreams and transform their experience into purpose.
The Cancer Letter’s coverage of HHS-led overhauls of foundational scientific institutions continued last week with two unrelated stories pointing to continued disarray amongst public health leadership.
Health and Human Services Secretary Robert F. Kennedy Jr. is moving to overhaul the U.S. Preventive Services Task Force, a highly influential panel that determines which preventive services insurers must cover and guides routine medical care for millions of Americans.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, or ACIP, voted in December to rescind its recommendation that all newborns receive a hepatitis B virus vaccine dose within 24 hours of birth.
